Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Bristol Myers Squibb Co | BMY | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.06 | 0.12% | 49.80 | 49.83 | 49.46 | 49.74 | 49.74 | 10:12:25 |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 6,798 | 919,165 | $ 49.70 | $ 45,682,642 | 10,737,074 | 41.19 - 63.69 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 10:12:25 | 100 | $ 49.80 | USD |
Bristol Myers Squibb Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 81.25B | 1.64B | $ 4.92B | 3.01 | 13.10 | 1.63B |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 144.02M | $ 0.41 | 0.83% | 10/03/19 | - | - |
Bristol Myers Squibb News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BMY Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol [m] | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 48.76 | 50.35 | 48.56 | 49.5678 | 9M | 1.04 | 2.13% |
| 1 Month | 47.98 | 50.35 | 46.285 | 48.2651 | 10M | 1.82 | 3.79% |
| 3 Months | 45.86 | 50.35 | 41.19 | 45.9868 | 12M | 3.94 | 8.59% |
| 6 Months | 50 | 50.5 | 41.19 | 46.5157 | 14M | -0.2 | -0.40% |
| 1 Year | 61.18 | 63.69 | 41.19 | 48.7361 | 13M | -11.38 | -18.60% |
| 3 Years | 55.95 | 70.05 | 41.19 | 52.8486 | 10M | -6.15 | -10.99% |
| 5 Years | 51.05 | 77.12 | 41.19 | 56.0081 | 8M | -1.25 | -2.45% |
Bristol Myers Squibb Description
| Bristol-Myers Squibb Co discovers, develops, and markets drugs for various indications, such as cardiovascular, oncology, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is leading in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs. |
